Cipla schedules AGM

Cipla schedules AGM on 26 August 2022

capital market | Mumbai 12:03 IST | August 09, 2022

Cipla is heavily leveraging digitalization, focusing on new markets

While keeping an eye on anticipated complicated product launches in the second half of the current fiscal year, it is also trying to ramp up its US core formulations sales on the strength of respiratory and peptide businesses....

India Infoline News Service | Mumbai 07:45 IST | August 08, 2022

Cipla EU to acquire additional 19.16% stake in Cipla Moroc SA

Cipla EU to acquire additional 19.16% stake in Cipla Moroc SA cipla EU to acquire additional 19.16% stake in Cipla Moroc SA

capital market | Mumbai 10:45 IST | August 05, 2022

Ciplas UK arm to acquire additional 19.16% stake in JV Cipla Maroc

The JV Co. has enabled Cipla to establish a front-end participation in Morocco's pharmaceutical market....

India Infoline News Service | Mumbai 09:50 IST | August 05, 2022

HDFC, SBI, Cipla, DLF, Bank of Baroda in focus

HDFC, SBI, Cipla, DLF, Bank of Baroda in focus hDFC, SBI, Cipla, DLF, Bank of Baroda in focus

capital market | Mumbai 08:28 IST | August 01, 2022

Cipla appoints director

Cipla appoints director with effect from 29 July 2022

capital market | Mumbai 12:04 IST | July 30, 2022

Cipla consolidated net profit declines 3.96% in the June 2022 quarter

Cipla consolidated net profit declines 3.96% in the June 2022 quarter sales decline 2.79% to Rs 5317.87 crore

capital market | Mumbai 17:37 IST | July 29, 2022

Cipla Q1 PAT slides 4% YoY to Rs 686 cr

Cipla Q1 PAT slides 4% YoY to Rs 686 cr ciplas consolidated net profit slipped 4% to Rs 686.40 crore on 2.3% decline in total revenue from operations to Rs 5,375.19 crore in Q1 FY23 over Q1 FY22.

capital market | Mumbai 16:59 IST | July 29, 2022

Cipla Limited - Outcome of Board Meeting

Cipla Limited - Outcome of Board Meeting cipla Limited - Outcome of Board Meeting

capital market | Mumbai 00:00 IST | July 29, 2022

Q1 FY23 Preview: Cipla: Revenue seen at Rs53,720 million; PAT at Rs5,770 million

Company's performance will be impacted by intense competition in generic drugs markets in US and India...

India Infoline News Service | Mumbai 14:23 IST | July 28, 2022

Cipla Health to acquire Endura Mass

Forays into the growing nutritional wellness space....

India Infoline News Service | Mumbai 09:17 IST | July 15, 2022

ACC, Tata Elxsi, Angel One, Cipla in focus

ACC, Tata Elxsi, Angel One, Cipla in focus aCC, Tata Elxsi, Angel One, Cipla in focus

capital market | Mumbai 08:55 IST | July 15, 2022

Cipla forays into nutritional wellness space; buys Endura Mass brand

Cipla forays into nutritional wellness space; buys Endura Mass brand the drug major said its wholly-owned subsidiary, Cipla Health, has signed definitive agreements for acquisition of Endura Mass from Medinnbelle Herbalcare.

capital market | Mumbai 08:37 IST | July 15, 2022

Cipla allots 85,273 equity shares under ESOS

Cipla allots 85,273 equity shares under ESOS cipla allots 85,273 equity shares under ESOS

capital market | Mumbai 14:58 IST | July 12, 2022

Rx and market share trends for key US products: IIFL Securities

In this report, analysts at IIFL Securities highlight prescription volumes and market share trends for the key US products for Indian generic companies....

India Infoline News Service | Mumbai 11:42 IST | July 12, 2022

Cipla to further invest Rs26 crore in GoApptive to raise stake to 22%

GoApptiv is a digital tech-company engaged in the business of offering digital solutions to pharmaceutical companies....

India Infoline News Service | Mumbai 09:19 IST | June 28, 2022

Cipla eyes 21% stake in diagnostic player Achira Labs; stock skids ~1%

This investment will mark Ciplas strategic participation in the PoC diagnostics and AMR (antimicrobial resistance) space through the design, development, and manufacturing of microfluidics-based technologies....

India Infoline News Service | Mumbai 10:03 IST | June 20, 2022

Cipla, Aurobindo Pharma, Alkem Laboratories in focus

Cipla, Aurobindo Pharma, Alkem Laboratories in focus cipla, Aurobindo Pharma, Alkem Laboratories in focus

capital market | Mumbai 08:42 IST | June 20, 2022

Cipla to acquire 21% stake in Achira Labs for Rs 25 cr

Cipla to acquire 21% stake in Achira Labs for Rs 25 cr the pharmaceutical company on Friday announced that it has signed definitive agreements to acquire 21.05% stake (on a fully diluted basis) in Achira Labs for a cash consideration of Rs 25 crores.

capital market | Mumbai 15:02 IST | June 18, 2022